Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Bond Issue

11 Jun 2025 09:37

RNS Number : 3871M
Experian plc
11 June 2025
Β 

Β 

Experian plc

Β 

Β 

Bond Issue

Β 

Β 

11 June 2025 - Experian plc, the global data and technology company, announces that its subsidiary, Experian Finance plc, rated A3 / A-, has priced an issue of $500million 5.250% bonds due 17 August 2035 (the "Notes"). The Notes will be issued by Experian Finance plc and guaranteed byΒ Experian plc.

Β 

This bond issue extends the maturity of the Group's debt portfolio and diversifies its funding sources. The net proceeds of the offering will be used for general corporate purposes, including potential acquisitions and the repayment of debt. The issue is scheduled to close on 17 June 2025, subject to customary conditions.

Β 

It is expected that the Notes will be admitted to the official list of Euronext Dublin and admitted to trading on the Global Exchange Market.

Β 

The Notes are being sold to qualified institutional buyers in the United States in accordance with Rule 144A under the US Securities Act of 1933Β ("Securities Act"), and to non-US persons outside the United States in reliance upon Regulation S under the Securities Act. The Notes and the guarantee have not been, and will not be, registered under the Securities Act, or the securities laws of any state of the United States or other jurisdiction, and may not be offered or sold in the United Sates, or to, or for the account or benefit of, US persons, other than pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Β 

This announcement does not constitute or form part of any offer or any solicitation to purchase nor shall it, or the fact of its distribution, form the basis of, or be relied on in any purchase. The distribution of this announcement and any subsequent offer of securities may be restricted by law in certain jurisdictions and persons receiving this announcement or any subsequent offer should inform themselves about and observe any such restriction. Failure to comply with such restrictions may violate securities laws of any such jurisdiction.

Β 

Β 

Contact:

Β 

Experian

Remco de Vries Group Treasurer +353 (0) 86 380 2791

Lorraine Keogh Deputy Group Treasurer +353 (0) 86 380 2193

Β 

Β 

About Experian

Β 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IODSFISAFEISEDM
Date   Source Headline
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20239:30 amRNSAdditional Listing
1st Feb 20239:15 amRNSAdditional Listing
31st Jan 20232:30 pmRNSDirector Declaration
31st Jan 202310:15 amRNSTotal Voting Rights
25th Jan 20239:15 amRNSAdditional Listing
17th Jan 20237:00 amRNSExperian Q3 FY23 trading update
13th Jan 20235:20 pmRNSFirst interim dividend
9th Jan 20237:00 amRNSDirectorate Change
30th Dec 202210:15 amRNSTotal Voting Rights
16th Dec 202211:30 amRNSElections for first interim dividend
14th Dec 20229:15 amRNSAdditional Listing
7th Dec 20229:00 amRNSAdditional Listing
30th Nov 202211:59 amRNSTotal Voting Rights
16th Nov 20227:00 amRNSHalf-year Report
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme
6th Oct 20227:00 amRNSDirectorate Change
5th Oct 20229:10 amRNSAdditional Listing
30th Sep 202212:06 pmRNSTotal Voting Rights
28th Sep 20229:02 amRNSAdditional Listing
19th Sep 202210:00 amRNSBlock listing Interim Review
14th Sep 20229:30 amRNSAdditional Listing
7th Sep 20229:30 amRNSAdditional Listing
31st Aug 202210:07 amRNSTotal Voting Rights
31st Aug 20229:30 amRNSAdditional Listing
17th Aug 20229:30 amRNSAdditional Listing
10th Aug 20229:15 amRNSAdditional Listing
29th Jul 20229:57 amRNSTotal Voting Rights
28th Jul 20229:25 amRNSDirector/PDMR Shareholding
21st Jul 202211:15 amRNSResult of AGM
21st Jul 202210:30 amRNSDirector Declaration
20th Jul 20229:30 amRNSAdditional Listing
14th Jul 20227:00 amRNSTrading update, first quarter
1st Jul 20225:42 pmRNSSecond Interim Dividend
30th Jun 20225:50 pmRNSTransaction in Own Shares
30th Jun 20224:00 pmRNSDirector/PDMR Shareholding
30th Jun 202210:54 amRNSTotal Voting Rights
29th Jun 20225:12 pmRNSTransaction in Own Shares
28th Jun 20225:28 pmRNSTransaction in Own Shares
27th Jun 20225:14 pmRNSTransaction in Own Shares
27th Jun 20222:15 pmRNSHolding(s) in Company
24th Jun 20225:41 pmRNSTransaction in Own Shares
24th Jun 202210:51 amRNSDirector/PDMR Shareholding
23rd Jun 20225:19 pmRNSTransaction in Own Shares
22nd Jun 20225:50 pmRNSTransaction in Own Shares
20th Jun 20225:26 pmRNSTransaction in Own Shares
17th Jun 20225:10 pmRNSTransaction in Own Shares
16th Jun 20225:33 pmRNSTransaction in Own Shares
15th Jun 20226:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.